Link to this page
National Cancer Institute Thesaurus
Last uploaded:
July 2, 2026
| Id | http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28811
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C28811
|
|---|---|
| Preferred Name | Adefovir Dipivoxil |
| Definitions |
A dipivoxil formulation of adefovir, a nucleoside reverse transcriptase inhibitor analog of adenosine with activity against hepatitis B virus (HBV), herpes virus, and human immunodeficiency virus (HIV).
|
| Synonyms |
ADEFOVIR DIPIVOXIL
Adefovir Dipivoxil
GS-0840
Hepsera
|
| Type | http://www.w3.org/2002/07/owl#Class |
All Properties
| label | Adefovir Dipivoxil
|
|---|---|
| prefixIRI | Thesaurus:C28811
|
| code | C28811
|
| DEFINITION | A dipivoxil formulation of adefovir, a nucleoside reverse transcriptase inhibitor analog of adenosine with activity against hepatitis B virus (HBV), herpes virus, and human immunodeficiency virus (HIV).
|
| Legacy Concept Name | Adefovir
|
| PDQ_Open_Trial_Search_ID | 543979
|
| Contributing_Source | FDA
|
| Accepted_Therapeutic_Use_For | Chronic Hepatitis B
|
| NCI_Drug_Dictionary_ID | 543979
|
| FULL_SYN |
ADEFOVIR DIPIVOXIL
Adefovir Dipivoxil
GS-0840
Hepsera
|
| Chemical_Formula | C20H32N5O8P
|
| UMLS_CUI | C0540694
|
| FDA_UNII_Code | U6Q8Z01514
|
| Preferred_Name | Adefovir Dipivoxil
|
| type | |
| subClassOf | |
| PDQ_Closed_Trial_Search_ID | 543979
|
| CAS_Registry | 142340-99-6
|
| Concept_In_Subset | |
| Semantic_Type |
Pharmacologic Substance
Nucleic Acid, Nucleoside, or Nucleotide
|
| Delete | Subject | Author | Type | Created |
|---|---|---|---|---|
| No notes to display |